RecruitingNot ApplicableNCT05890417
Evolution of Sexual Life Quality of Women With POI Before and After Introduction of Hormone Replacement Therapy
Sponsor
University Hospital, Bordeaux
Enrollment
135 participants
Start Date
Jul 17, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to evaluate the evolution of quality of sex life of women with POI after introduction hormone replacement therapy through the FSFI scale
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years
Inclusion Criteria4
- positive diagnosis of POI (amenorrhea \> 4 months or spaniomenorrhea \> 4 months and FSH \> 25 IU/L checked twice, more than 4 weeks apart)
- absence of hormonal treatment,
- patient's oral consent,
- affiliated or beneficiary of health insurance
Exclusion Criteria3
- contraindication to hormonal treatment (history of hormone-dependent cancer, history of ischemic arterial stroke),
- inability of the patient to understand the nature or risks or significance and implications of the clinical investigation,
- patient under legal protection
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERquestionnaire
Female Sexual Function Index (FSFI) and WHO Quality of Life-BREF (WHOQOL-BREF) questionnaires at baseline and 6 months after starting hormone replacement therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05890417